Oslo, 6 September 2021: Option holders under NEXT Biometrics Group ASA's (the
"Company", OSE ticker: NEXT) share option programs have today exercised a total
of 167,877 options as set out below and as per the terms and conditions of the
share option programs. The exercised options will be settled by issuance of new
shares in the Company.
o	In total 48,500 options were exercised at NOK 2.49 per option.
o	In total 91,670 options were exercised at NOK 5.97 per option.
o	In total 27,707 options were exercised at NOK 6.52 per option.

Further to the above, the board of directors of the Company has in a board
meeting held today, on 6 September 2021, resolved to increase the Company's
share capital with NOK 167,877 by the issuance of 167,877 new shares, each with
a nominal value of NOK 1.00. The share issue was resolved pursuant to an
authorization to increase the Company's share capital granted by the annual
general meeting of shareholders on 12 May 2021, and for the purpose of
facilitating settlement of the exercised options. The exercise period for the
options commenced on 31 August 2021 at 10:00 hours (CEST) and ended on today, on
6 September 2021, at 10:00 hours (CEST).

All of the exercised options have been granted under the Company's share option
program, as described in the Company's latest annual financial statements and
report, which is based on guidelines approved by the general meeting of
shareholders.

Following the registration of the share capital increase with the Norwegian
Register of Business Enterprises (Nw. Foretaksregisteret), the new share capital
of the Company will be NOK 91,680,763, divided into 91,680,763 shares, each with
a nominal value of NOK 1.00. The share capital increase will be registered with
the Norwegian Register of Business Enterprises as soon as practically possible
after the share contribution has been paid in full.

This information is subject to the disclosure requirements pursuant to Article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.

NEXT Investor contact:
Peter Heuman (CEO), peter.heuman@nextbiometrics.com
Eirik Underthun (CFO), eirik.underthun@nextbiometrics.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange